FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Sustainability Profile
FUJIFILM Diosynth Biotechnologies U.S.A., Inc., a prominent player in the biopharmaceutical industry, is headquartered in Grand Island, New York, with significant operations across the United States and Europe. Founded in 2012, the company has rapidly established itself as a leader in biomanufacturing, specialising in the development and production of biologics, including monoclonal antibodies and recombinant proteins. With a commitment to innovation, FUJIFILM Diosynth offers unique services such as cell line development, process development, and large-scale manufacturing, utilising cutting-edge technologies to ensure high-quality outputs. The company has achieved notable milestones, including partnerships with major pharmaceutical firms, solidifying its market position as a trusted contract development and manufacturing organisation (CDMO). Through its dedication to excellence, FUJIFILM Diosynth continues to advance the biopharmaceutical landscape, supporting the delivery of life-saving therapies worldwide.
DitchCarbon Score
How does FUJIFILM Diosynth Biotechnologies U.S.A., Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.'s score of 57 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.'s reported carbon emissions
FUJIFILM Diosynth Biotechnologies U.S.A., Inc., headquartered in Great Britain, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of FUJIFILM Holdings Corporation, which influences its climate commitments and initiatives. While no specific reduction targets or achievements are listed for FUJIFILM Diosynth Biotechnologies U.S.A., Inc., it is important to note that the broader corporate family, including FUJIFILM Holdings Corporation, is engaged in various climate initiatives. These initiatives include commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded down to the subsidiary level. As a part of its corporate responsibility, FUJIFILM Diosynth Biotechnologies U.S.A., Inc. aligns with the sustainability goals set by its parent company, which aims to reduce overall carbon emissions and enhance environmental stewardship. However, specific details regarding emissions reductions or targets at the subsidiary level remain unspecified.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 19,845,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 23,798,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000,000 |
How Carbon Intensive is FUJIFILM Diosynth Biotechnologies U.S.A., Inc.'s Industry?
How Carbon Intensive is FUJIFILM Diosynth Biotechnologies U.S.A., Inc.'s Location?
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
FUJIFILM Diosynth Biotechnologies U.S.A., Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.